Clinical Research Details

Back to List
Descriptive Information
Public health nutrition intervention to enhance healthy eating and lifestyle modification among Lebanese patients with polycystic ovarian syndrome

Ghina Ghazeeri
gg02@aub.edu.lb

OGY.GG.13
Completed

Clinical Research - Therapeutic interventions  


No
Collaborators
  • Caroline Hamadi
  • Dr. Ihab Tewfik
  • Dr. Lorna Tinworth
Coordinators
Caroline Hamadi
ch44@aub.edu.lb
Conditions and Keywords
Polycystic ovary syndrome,Obesity
Polycystic ovary syndrome ,obesity,Physical activity ,weight managment
Study Design
Health Services Research
Safety and/or Efficacy Study
N/A: Not Applicable
Parallel-Group
Randomized
N/A: Not Applicable
Eligibility and IRB
Female
Min: 18
Max: 49
Yes
No


Patients will be subjected to a face-to-face questionnaire regarding socio- demographic variables, nutritional status, and physical activity, psychological and medical status. Moreover, blood will be withdrawn and biochemical analysis will be done. Assessment will be at baseline as well as after 3 and 6 months from the intervention. Within the tailored nutrition counseling/education program, patients will attend 3 sessions over 6 months about diet and weight management, physical activity, and healthy cooking, lifestyle, and food shopping.

This project is divided into two phases, a pilot study and a larger scale up intervention that will take place after the pilot study.

The results of this study will serve as a basis for developing the nutritional framework for treating people suffering from PCOS and managing its complications.

Adults with PCOS will be recruited from the obstetrics and gynecology clinic at the American University of Beirut Medical Center (AUB-MC).

purposeful sampling

  • Diagnosed with PCOS according to the Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group, 2003.
  • Patients with Cushing’s syndrome, thyroid disease, cancer, kidney or liver disease
  • Patients following a structural weight loss program
  • Women with history of daily physical activity more than 30 minutes 5 days weekly (in order to have matched controls and intervention groups).
  • Patients on metformin medication (note that patients on metformin are excluded because metformin can cause weight loss which will give us false positive results).
Back to List